Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
24-10-17 Rigla OOO and Public Joint-Stock Company PROTEK acquired Prime-Pharm LLC, Apteka 52 LLC, First Pharmacy LLC, Solo-Pharm LLC, Nizhegorodskaya Pharmacy LLC network, LLC ? First Pharmacy, LLC ?Pharmacy 24, LLC, Vita+, LLC, Pharmacy 78, LLC and Premier-pharm?, LLC from Yuri Gaysinsky. CI
20-04-29 Public Joint-Stock Company Protek Reports Earnings Results for the Full Year Ended December 31, 2019 CI
18-08-27 Protek Group Reports Consolidated Earnings Results for the First Half of 2018 CI
17-12-03 JSC Rafarma announced that it has received funding from Public Joint-Stock Company PROTEK CI
17-11-26 Protek OOO acquired an additional 0.19% stake in Public Joint-Stock Company PROTEK. CI
17-11-22 Protek LLC acquired an additional 0.0522% stake in Public Joint-Stock Company PROTEK. CI
17-10-25 PROTEK Group Announces Unaudited Consolidated Revenue Results for Third Quarter and Nine Months Ended September 30, 2017 CI
17-08-25 The Protek Reports Consolidated Earnings Results for the First Half of Fiscal Year 2017 CI
17-04-19 PROTEK Group Reports Audited Consolidated Earnings Results for the Year 2016 CI
17-04-17 Open Joint Stock Company Protek completed the acquisition of Joint Stock Company Rafarma from Rafarma Pharmaceuticals, Inc.. CI
17-02-09 PROTEK Group Reports Preliminary Consolidated Unaudited Revenue Results for Fourth Quarter and Full Year 2016 CI
16-12-22 Open Joint Stock Company Protek sold 51% stake in Firma Koman Zao. CI
16-11-15 Ortes ZAO acquired LLC Protek Finance from Public Joint-Stock Company PROTEK. CI
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Executive Officer 68 2014-09-30
Corporate Officer/Principal 69 2002-12-31
Director TitleAgeSince
Director/Board Member 69 2001-12-31
Chairman 63 2001-12-31
Director/Board Member 63 2011-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.10% - - 601M
-0.85%+5.34%-7.17%+5.66% 5.94B
-1.28%+2.72%-6.81%+48.76% 3.38B
-1.42%+3.98%-31.82%-12.18% 3.04B
-0.16%+1.38%-12.98%-8.63% 2.81B
-0.55%+3.51%+8.29%+49.07% 2.25B
-1.35%-0.68%-43.95%-50.59% 1.33B
-0.45%+1.55%+5.80%-5.87% 1.32B
-0.67%-5.10%+7.54%-24.62% 808M
+2.18%+5.07%+28.47%+60.58% 474M
Average -0.46%+2.80%-5.85%+6.91% 2.37B
Weighted average by Cap. -0.78%+4.64%-9.89%+8.50%
Logo PROTEK
Protek PAO is a Russia-based vertically integrated pharmaceutical holding company. Together with its subsidiaries, the Company forms Protek Group, which is engaged in various segments of the pharmaceutical industry. The Company focuses on such business segments as: Distribution, Retail and Production. The Company has three plants involved in the pharmaceuticals, beauty and health products manufacture: FarmFirma Soteks ZAO, Protek-SVM OOO and Proteinovyi Kontur OOO. The Company operates through numerous subsidiaries and affiliated companies, located domestically and in Ukraine, the Virgin Islands and Cyprus.
Employees
-
  1. Stock Market
  2. Stocks
  3. PRTK Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!